RADNET INC (RDNT) Stock Fundamental Analysis
NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
RDNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 105 industry peers in the Health Care Providers & Services industry. RDNT has an average financial health and profitability rating. While showing a medium growth rate, RDNT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
RDNT had positive earnings in the past year.
RDNT had a positive operating cash flow in the past year.
Of the past 5 years RDNT 4 years were profitable.
Each year in the past 5 years RDNT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of RDNT (0.08%) is comparable to the rest of the industry.
RDNT has a Return On Equity (0.31%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.27%, RDNT perfoms like the industry average, outperforming 48.11% of the companies in the same industry.
RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 8.81%.
The 3 year average ROIC (2.96%) for RDNT is below the current ROIC(3.27%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.08% | ||
| ROE | 0.31% | ||
| ROIC | 3.27% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
The Profit Margin of RDNT (0.15%) is comparable to the rest of the industry.
RDNT's Profit Margin has declined in the last couple of years.
The Operating Margin of RDNT (6.08%) is better than 66.04% of its industry peers.
RDNT's Operating Margin has been stable in the last couple of years.
RDNT has a Gross Margin (24.03%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RDNT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.08% | ||
| PM (TTM) | 0.15% | ||
| GM | 24.03% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
RDNT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, RDNT has more shares outstanding
RDNT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that RDNT is in the distress zone and has some risk of bankruptcy.
RDNT's Altman-Z score of 1.77 is in line compared to the rest of the industry. RDNT outperforms 45.28% of its industry peers.
The Debt to FCF ratio of RDNT is 22.61, which is on the high side as it means it would take RDNT, 22.61 years of fcf income to pay off all of its debts.
RDNT has a Debt to FCF ratio (22.61) which is in line with its industry peers.
RDNT has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
RDNT's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. RDNT is outperformed by 65.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 22.61 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.37
WACC8.81%
2.3 Liquidity
A Current Ratio of 2.12 indicates that RDNT has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.12, RDNT is doing good in the industry, outperforming 74.53% of the companies in the same industry.
A Quick Ratio of 2.12 indicates that RDNT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.12, RDNT is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.12 |
3. Growth
3.1 Past
RDNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.00%, which is quite impressive.
Measured over the past years, RDNT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.79% on average per year.
The Revenue has grown by 13.17% in the past year. This is quite good.
The Revenue has been growing by 9.65% on average over the past years. This is quite good.
EPS 1Y (TTM)26%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%10%
Revenue 1Y (TTM)13.17%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.49%
3.2 Future
RDNT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.84% yearly.
The Revenue is expected to grow by 7.67% on average over the next years.
EPS Next Y-29.14%
EPS Next 2Y8.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.48%
Revenue Next 2Y7.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 79.02, RDNT can be considered very expensive at the moment.
RDNT's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of RDNT to the average of the S&P500 Index (28.29), we can say RDNT is valued expensively.
RDNT is valuated quite expensively with a Price/Forward Earnings ratio of 111.51.
RDNT's Price/Forward Earnings is on the same level as the industry average.
RDNT is valuated expensively when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 79.02 | ||
| Fwd PE | 111.51 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as RDNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 83 | ||
| EV/EBITDA | 12.94 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)4.71
EPS Next 2Y8.84%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
49.78
-0.74 (-1.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.9%
Inst Owner Change0.07%
Ins Owners10.8%
Ins Owner Change1.12%
Market Cap3.73B
Analysts86.67
Price Target76.84 (54.36%)
Short Float %8.65%
Short Ratio6.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.43%
Min EPS beat(2)5.99%
Max EPS beat(2)20.87%
EPS beat(4)3
Avg EPS beat(4)323.45%
Min EPS beat(4)-5.6%
Max EPS beat(4)1272.55%
EPS beat(8)6
Avg EPS beat(8)197.43%
EPS beat(12)7
Avg EPS beat(12)-244.9%
EPS beat(16)10
Avg EPS beat(16)-165.48%
Revenue beat(2)2
Avg Revenue beat(2)2.27%
Min Revenue beat(2)1.29%
Max Revenue beat(2)3.25%
Revenue beat(4)4
Avg Revenue beat(4)1.92%
Min Revenue beat(4)0.36%
Max Revenue beat(4)3.25%
Revenue beat(8)8
Avg Revenue beat(8)1.65%
Revenue beat(12)10
Avg Revenue beat(12)1.74%
Revenue beat(16)12
Avg Revenue beat(16)1%
PT rev (1m)-9.6%
PT rev (3m)-16.45%
EPS NQ rev (1m)-10.03%
EPS NQ rev (3m)-331.32%
EPS NY rev (1m)-32.52%
EPS NY rev (3m)-40.86%
Revenue NQ rev (1m)-0.81%
Revenue NQ rev (3m)-5.34%
Revenue NY rev (1m)-1.55%
Revenue NY rev (3m)-2.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 79.02 | ||
| Fwd PE | 111.51 | ||
| P/S | 2.04 | ||
| P/FCF | 83 | ||
| P/OCF | 16.01 | ||
| P/B | 4.13 | ||
| P/tB | 33.83 | ||
| EV/EBITDA | 12.94 |
EPS(TTM)0.63
EY1.27%
EPS(NY)0.45
Fwd EY0.9%
FCF(TTM)0.6
FCFY1.2%
OCF(TTM)3.11
OCFY6.25%
SpS24.41
BVpS12.04
TBVpS1.47
PEG (NY)N/A
PEG (5Y)4.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.08% | ||
| ROE | 0.31% | ||
| ROCE | 3.96% | ||
| ROIC | 3.27% | ||
| ROICexc | 4.43% | ||
| ROICexgc | 7.19% | ||
| OM | 6.08% | ||
| PM (TTM) | 0.15% | ||
| GM | 24.03% | ||
| FCFM | 2.46% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 22.61 | ||
| Debt/EBITDA | 3.2 | ||
| Cap/Depr | 94.8% | ||
| Cap/Sales | 10.28% | ||
| Interest Coverage | 1.32 | ||
| Cash Conversion | 75.25% | ||
| Profit Quality | 1609.49% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.12 | ||
| Altman-Z | 1.77 |
F-Score6
WACC8.81%
ROIC/WACC0.37
Cap/Depr(3y)97.03%
Cap/Depr(5y)109.5%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%10%
EPS Next Y-29.14%
EPS Next 2Y8.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.17%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.49%
Revenue Next Year6.48%
Revenue Next 2Y7.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.77%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year109.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.56%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y5.51%
OCF growth 3Y15.95%
OCF growth 5Y17.44%